Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-25-010594·Enveric Biosciences, Inc.
Schedule 13G ownership disclosure
ENVERIC BIOSCIENCES INC
Common stock, par value $0.01 per share · CUSIP: 29405E406
Event date: 2025-01-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Mitchell P. Kopin
Shares: 103,951.00 · Class: 4.99%
- Daniel B. Asher
Shares: 103,951.00 · Class: 4.99%
- Intracoastal Capital LLC
Shares: 103,951.00 · Class: 4.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-010594
- Form type
- SCHEDULE 13G
- Filer
- Enveric Biosciences, Inc.
- CIK
- CIK 890821
- Filed
- Feb 05, 2025
- Reporting period
- Jan 30, 2025
- Description
- Schedule 13G beneficial ownership